--------------------------------------------------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): November 19, 2007
ORION HEALTHCORP, INC.
(Exact Name of Registrant as Specified in its Charter)
Delaware 001-16587 58-1597246
(State or Other (Commission File (I.R.S. Employer
Jurisdiction of Number) Identification
Incorporation) Number)
1805 Old Alabama Road, Suite 350
Roswell, GA 30076
(Address of Principal Executive Offices) (Zip Code)
(678) 832-1800
(Registrant's Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
|_| Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
--------------------------------------------------------------------------------
Item 3.01 Notice of Delisting.
(d) On November 19, 2007, Orion HealthCorp, Inc. (the "Company")
notified the American Stock Exchange (the "AMEX") that it intends
to voluntarily delist its Class A Common Stock, $0.001 par value
(the "Common Stock"), from the AMEX upon approval of the proposal
(the "Proposal") to be voted on at the Company's special
stockholders' meeting to be held on Thursday, November 29, 2007.
The Proposal is described in detail in the Schedule 14A
definitive proxy statement filed with the Securities and Exchange
Commission (the "SEC") on November 14, 2007 and mailed to the
Company's stockholders. If the Proposal is approved by its
stockholders, the Company will proceed with the voluntary
delisting and promptly file Form 25 with the SEC. If the Proposal
is not approved by its stockholders, the Company will promptly
notify the AMEX that it is withdrawing its request to voluntarily
delist the Common Stock.
Additionally, on November 19, 2007, the Company issued a press
release regarding the aforementioned delisting from AMEX. The
press release is attached as Exhibit 99.1 to this current report.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits - The following exhibits are furnished as part of this current
report:
Exhibit Description
99.1 Copy of press release issued by the Company on November 19, 2007.
SIGNATURES
----------
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Company has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ORION HEALTHCORP, INC.
By: /s/ Terrence L. Bauer
---------------------------
Terrence L. Bauer
Chief Executive Officer
Date: November 19, 2007
EXHIBIT INDEX
Exhibit
Number Description of Exhibits
------- -----------------------
99.1 Copy of press release issued by the Company on November 19, 2007.